Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

Related Citations for PubMed (Select 17699774)

1.

Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.

Gavert N, Sheffer M, Raveh S, Spaderna S, Shtutman M, Brabletz T, Barany F, Paty P, Notterman D, Domany E, Ben-Ze'ev A.

Cancer Res. 2007 Aug 15;67(16):7703-12.

2.

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.

Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, Ben-Ze'ev A.

J Cell Biol. 2005 Feb 14;168(4):633-42.

3.

L1-CAM in cancerous tissues.

Gavert N, Ben-Shmuel A, Raveh S, Ben-Ze'ev A.

Expert Opin Biol Ther. 2008 Nov;8(11):1749-57. doi: 10.1517/14712598.8.11.1749 . Review.

PMID:
18847309
4.

L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.

Gavert N, Vivanti A, Hazin J, Brabletz T, Ben-Ze'ev A.

Mol Cancer Res. 2011 Jan;9(1):14-24. doi: 10.1158/1541-7786.MCR-10-0406. Epub 2010 Dec 1.

5.

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

Lee SB, Schramme A, Doberstein K, Dummer R, Abdel-Bakky MS, Keller S, Altevogt P, Oh ST, Reichrath J, Oxmann D, Pfeilschifter J, Mihic-Probst D, Gutwein P.

J Invest Dermatol. 2010 Mar;130(3):763-73. doi: 10.1038/jid.2009.335. Epub 2009 Oct 29.

6.

The cell adhesion nectin-like molecules (Necl) 1 and 4 suppress the growth and tumorigenic ability of colon cancer cells.

Raveh S, Gavert N, Spiegel I, Ben-Ze'ev A.

J Cell Biochem. 2009 Sep 1;108(1):326-36. doi: 10.1002/jcb.22258.

PMID:
19565570
7.

Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.

Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, Laé M, Louvard D, Ben-Ze'ev A, Robine S.

Cancer Res. 2007 Jul 15;67(14):6844-53.

8.

The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.

Doberstein K, Pfeilschifter J, Gutwein P.

Carcinogenesis. 2011 Nov;32(11):1713-23. doi: 10.1093/carcin/bgr195. Epub 2011 Aug 30.

9.

PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.

Brunschwig EB, Wilson K, Mack D, Dawson D, Lawrence E, Willson JK, Lu S, Nosrati A, Rerko RM, Swinler S, Beard L, Lutterbaugh JD, Willis J, Platzer P, Markowitz S.

Cancer Res. 2003 Apr 1;63(7):1568-75.

10.

The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.

Stein U, Arlt F, Walther W, Smith J, Waldman T, Harris ED, Mertins SD, Heizmann CW, Allard D, Birchmeier W, Schlag PM, Shoemaker RH.

Gastroenterology. 2006 Nov;131(5):1486-500. Epub 2006 Aug 22.

PMID:
17101323
11.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
12.

Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity.

Riedle S, Kiefel H, Gast D, Bondong S, Wolterink S, Gutwein P, Altevogt P.

Biochem J. 2009 May 27;420(3):391-402. doi: 10.1042/BJ20081625.

13.

Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.

Ben-Shmuel A, Shvab A, Gavert N, Brabletz T, Ben-Ze'ev A.

Oncogene. 2013 Jul 4;32(27):3220-30. doi: 10.1038/onc.2012.340. Epub 2012 Aug 6.

PMID:
22869145
14.
15.

L1 cell adhesion molecule (L1CAM) in invasive tumors.

Raveh S, Gavert N, Ben-Ze'ev A.

Cancer Lett. 2009 Sep 18;282(2):137-45. doi: 10.1016/j.canlet.2008.12.021. Epub 2009 Jan 13. Review.

PMID:
19144458
16.

Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice.

Prinzen C, Trümbach D, Wurst W, Endres K, Postina R, Fahrenholz F.

BMC Genomics. 2009 Feb 5;10:66. doi: 10.1186/1471-2164-10-66.

17.

c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.

Gavert N, Shvab A, Sheffer M, Ben-Shmuel A, Haase G, Bakos E, Domany E, Ben-Ze'ev A.

Cancer Res. 2013 Sep 15;73(18):5754-63. doi: 10.1158/0008-5472.CAN-13-0576. Epub 2013 Sep 5.

18.

Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.

Calviello G, Resci F, Serini S, Piccioni E, Toesca A, Boninsegna A, Monego G, Ranelletti FO, Palozza P.

Carcinogenesis. 2007 Jun;28(6):1202-9. Epub 2006 Dec 20.

19.

Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.

Choi HN, Kim KR, Lee JH, Park HS, Jang KY, Chung MJ, Hwang SE, Yu HC, Moon WS.

Oncol Rep. 2009 Jan;21(1):57-63.

PMID:
19082443
20.

Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cells.

Tian X, Du H, Fu X, Li K, Li A, Zhang Y.

Biochem Biophys Res Commun. 2009 Mar 13;380(3):478-83. doi: 10.1016/j.bbrc.2009.01.124. Epub 2009 Jan 25.

PMID:
19284991
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk